Sort
40,608 grants matching “prostate cancer”
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,106,459Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2023 · CA
Bastyr/UW Oncomycology Translational Research Center
$1,106,200Leanna J Standish · Bastyr University · U19 · FY2011 · AT
EXTRACELLULAR HSP90 AS A NOVEL EPIGENETIC REGULATOR OF EMT AND METASTATIC RISK IN PROSTATE CANCER
$1,106,194The Medical University Of South Carolina · · FY2012 · Department of the Army
COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK
$1,106,093Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Targeted Discovery of Marine-derived Anticancer Leads
$1,105,895Phil Crews · University Of California Santa Cruz · U19 · FY2007 · CA
Metastasis of PTEN Mutant Prostate Cancer
$1,105,348Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
PROSTATE CANCER BIOREPOSITORY NETWORK (PCBN)
$1,105,314The Johns Hopkins University · · FY2018 · Defense Health Agency
PROSTATE CANCER BIOREPOSITORY NETWORK (PCBN)
$1,105,178The Johns Hopkins University · · FY2018 · Defense Health Agency
Administrative Core
$1,104,728Shafiq A Khan · Clark Atlanta University · G12 · FY2018 · MD
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,104,636Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2022 · CA
DCEG- GWAS Studies
$1,104,589Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
Comprehensive Assessment of Cancer Theranostics Response
$1,104,267Timothy Perk · Aiq Solutions, Inc. · R44 · FY2024 · CA
Discovery Expansion and Replication
$1,104,208Brian E Henderson · University Of Southern California · U19 · FY2011 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,103,993Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2019 · CA
Regulation Of Childhood Growth
$1,103,990Jeffrey Baron · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,103,826Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2020 · CA
Center for Interventional Oncology
$1,103,817Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
VACCINE IMMUNOTHERAPY FOR PROSTATE CANCER
$1,102,802The University Of Iowa · · FY2008 · Department of the Army
Development of a novel MYC inhibitor for cancer therapy
$1,102,729Ben Vollrath · Vortex Therapeutics Inc · R44 · FY2025 · CA
Telehealth Research and Innovation for Veterans with Cancer (THRIVE)
$1,102,149Scott E Sherman · New York University School Of Medicine · P50 · FY2023 · CA
The Role of the Integrated Stress Response in Cancer
$1,101,958Constantinos Koumenis · University Of Pennsylvania · P01 · FY2019 · CA
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership
$1,101,911James W Lillard · Morehouse School Of Medicine · U54 · FY2020 · CA
CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE
$1,101,485Shafiq A Khan · Clark Atlanta University · P20 · FY2013 · MD
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
$1,101,156Samuel E. Adunyah · Meharry Medical College · U54 · FY2024 · CA
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
$1,101,004Roberta M Troy · Tuskegee University · U54 · FY2018 · CA